InvestorsHub Logo
Followers 1055
Posts 189434
Boards Moderated 1
Alias Born 06/19/2009

Re: None

Sunday, 01/29/2017 10:58:01 AM

Sunday, January 29, 2017 10:58:01 AM

Post# of 50157
DCTH is defiantly not a scam. Management hasn't worked well for Shareholders so sar but i will take positive Phase 2/3 Data Cancer for a compensation. Those who claiming that or hasn't did DD or Trying to hurt the Comoany or both. FDA And CE Mark would have never been granted to a scam Company. 2 Rs's in 17 years. There are many companies doing even 3 Rs's per year.

The FDA has granted DCTH six orphan drug designations, including three orphan designations for the use of the drug melphalan for the treatment of patients with mOM, HCC and ICC. 

European Region: 
1. CE Marked as Class IIb Medical Device with broad indication 
2. >300 commercial procedures performed 
3. Expansion into Turkey March 2016 
4. National reimbursement established in Germany for 2016 after <3 years of commercial activity.

A busy weeks ahead start on Tuesday




My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DCTH News